AG002FVC

19237-84-4 | Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-, hydrochloride (1:1)

AG002FVC

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	19237-84-4
Catalog Number	AG002FVC(AGN-PC-0QL7ED)
Chemical Name	Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-, hydrochloride (1:1)
EC Number	242-903-4
IUPAC Name	[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone;hydrochloride
InChI	InChI=1S/C19H21N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22);1H
InChI Key	WFXFYZULCQKPIP-UHFFFAOYSA-N
MDL Number	MFCD00058177
Molecular Formula	C19H22ClN5O4
Molecular Weight	419.8621
SMILES	O=C(c1occc1)N4CCN(c2nc(N)c3cc(OC)c(OC)cc3(n2))CC4.[H]Cl
UNII	X0Z7454B90
Synonyms	Furazosin, HCL, Prazosin, Hydrochloride, Prazosin, Minipress, Pratsiol, Prazosin, Prazosin HCL, Prazosin Hydrochloride, Prazosin hydrochloride, 19237-84-4, Prazosin HCl, Minipress, Peripress, Vasoflex, Furazosin hydrochloride, Deprazolin, Hypovase, Hypovasole, Pratsiol, Sinetens, Minipress Xl, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine hydrochloride, Prazosin (hydrochloride), CP-12299-1, NSC 292810, Prazosin clorhidrato [Spanish], prazosine hydrochloride, UNII-X0Z7454B90, EINECS 242-903-4, MFCD00058177, C19H21N5O4.HCl, MLS000028454, (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)piperazine monohydrochloride, X0Z7454B90, SMR000058384, Minipress (TN), CP-12,299-1, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-, monohydrochloride, Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-, monohydrochloride, W-107719, 2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline hydrochloride, CHEBI:8365, Quinazoline, 4-amino-6,7-dimethoxy-2-(4-(2-furoyl)piperazin-1-yl)-, hydrochloride, HSDB, SR-01000003052, Adversuten, Adverszuten, Alpress LP, Prazosin hydrochloride [USAN:JAN], [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone;hydrochloride, Pressin and Hypovase, Prazosin hydrochloride [USAN:USP:JAN], Prazosin hydrochloride;, PubChem19837, Opera_ID_370, AC1Q5KOO, AC1L29YV, CHEMBL1558, SCHEMBL41257, MLS001148201, MLS001333696, MLS002153280, MLS002222304, SPECTRUM1500495, Prazosin HCl (Furazosin HCl), piperazin-1-yl)(furan-2-yl), CTK3J2335, HY-B0193A, KS-00000ZMQ, AOB5346, BBC/839, DTXSID50172822, SYN3017, WFXFYZULCQKPIP-UHFFFAOYSA-N, HMS1570N16, HMS1920J10, Pharmakon1600-01500495, BCP13643, ZX-AS005038, Prazosin hydrochloride (JP17/USP), Tox21_501002, AC-699, BG0291, CCG-39227, GP4454, NSC292810, NSC757286, s1424, AKOS015895394, AF-0012, API0003916, CS-2089, H37P844, LP01002, MCULE-7492026178, Minipress,Vasoflex,Pressin and Hypovase, NSC-292810, NSC-757286, RTR-008931, SB17352, VA11573, 2-[4-(furan-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxychinazolin-4-aminhydrochlorid, Prazosin hydrochloride, >=99% (TLC), NCGC00094296-01, NCGC00094296-02, NCGC00094296-03, NCGC00094296-04, NCGC00094296-05, NCGC00261687-01, AK132953, BC205115, CC-33905, H764, ST057530, AB0013242, AB2000097, CP-122991, LS-140003, TL8001578, TR-008931, EU-0101002, P0938, D00609, 19237-84-4,19216-56-9(freebase), I06-0650, SR-01000003052-2, SR-01000003052-8, Piperazine,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-, monohydrochloride, Prazosin hydrochloride, European Pharmacopoeia (EP) Reference Standard, Prazosin hydrochloride, United States Pharmacopeia (USP) Reference Standard, [4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanylmethanone Hydrochloride, 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonxyl)piperazine Hydrochloride, 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone, chloride, 4-Amino-6,7-dimethoxy-2-[4-(2-furoyl)piperazine-1-yl]quinazoline hydrochloride, Piperazine,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-, monohydrochloride, [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone hydrochloride, Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-, hydrochloride (1:1), prazosin, Furazosin, Lentopres, Prazosin clorhidrato, MINIZIDE, methanone hydrochloride, C19H22ClN5O4, C19H21N5O4.ClH, HSDB 3298, CID68546, C19-H21-N5-O4.Cl-H, AR-1D6940, RW2754, CS-O-11718, Prazosin hydrochloride, 98% - 1G 1g, A5318, (4-(4-amino-6,7-dimethoxyquinazolin-2-yl), A11914, 19216-56-9, 1-(3-AMINO-6,7-DIMETHOXY-2-QUINAZOLINY)-4-(2-FURANYLCARBONYL)PIPERAZINE, 92494-53-6, Metanona, [4-(4-amino-6,7-dimetoxi-2-quinazolinil)-1-piperacinil]-2-furanil, clorhidrato (1:1),

Complexity	544
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	419.136g/mol
Formal Charge	0
Heavy Atom Count	29
Hydrogen Bond Acceptor Count	8
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	419.866g/mol
Monoisotopic Mass	419.136g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	107A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number